Bibliography
MAINI, R. N., ELLIOTT, M. J., BRENNAN, E. M., WILLIAMS, R. O., CHU, C. Q., PALEOLOG, E., CHARLES, P. J., TAYLOR, P. C., & FELDMANN, M. (1995). Monoclonal antiâTNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease. Immunological Reviews, 144(1), 195â223. Portico.
References
103
Referenced
141
10.1111/j.1365-3083.1993.tb02592.x
{'key': 'e_1_2_1_3_1', 'first-page': '767', 'volume-title': 'Annual Review of Immunology', 'author': 'Bevilacqua M. P.', 'year': '1993'}
/ Annual Review of Immunology by Bevilacqua M. P. (1993){'key': 'e_1_2_1_4_1', 'first-page': '253', 'article-title': 'Effects of tumor necrosis factor alpha (TNF‐a) on collagen arthritis', 'author': 'Brahn E.', 'year': '1992', 'journal-title': 'Lymphokine & Cytokine Res.'}
/ Lymphokine & Cytokine Res. / Effects of tumor necrosis factor alpha (TNF‐a) on collagen arthritis by Brahn E. (1992)10.1016/0008-8749(84)90397-6
10.1016/S0140-6736(89)90430-3
10.1111/j.1365-2249.1990.tb03331.x
10.1002/eji.1830200938
{'key': 'e_1_2_1_9_1', 'first-page': '76', 'article-title': 'Cytokine expression in rheumatoid arthritis', 'volume': '1', 'author': 'Brennan F. M.', 'year': '1991', 'journal-title': 'Br. J. Rheumatol.'}
/ Br. J. Rheumatol. / Cytokine expression in rheumatoid arthritis by Brennan F. M. (1991)10.1016/0140-6736(93)92628-7
{'key': 'e_1_2_1_11_1', 'first-page': '295', 'article-title': 'Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukiti 2, IL‐2 receptor, and interferony', 'volume': '71', 'author': 'Buchan G.', 'year': '1988', 'journal-title': 'Clin. Exp. Immunol.'}
/ Clin. Exp. Immunol. / Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukiti 2, IL‐2 receptor, and interferony by Buchan G. (1988){'key': 'e_1_2_1_12_1', 'first-page': '449', 'article-title': 'Interleukin‐l and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL‐1 alpha', 'volume': '73', 'author': 'Buchan G.', 'year': '1988', 'journal-title': 'Clin. Exp. Immunol.'}
/ Clin. Exp. Immunol. / Interleukin‐l and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL‐1 alpha by Buchan G. (1988)10.1016/S0950-3579(05)80183-9
- Butler D. Maini R. N. Feldmann M.&Brennan F. M.Blockade of TNFα with chimeric anti TNFα monoclonal antibody cA2 reduces (IL‐6 and IL‐8) release in RA NMC cultures: A comparison with IL‐1ra. (manuscript submitted).
10.1126/science.7520605
10.1002/art.1780351107
10.1111/j.1365-3083.1992.tb03102.x
10.1002/art.1780340908
/ Arthritis Rheum. / Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage‐pannus junction in patient with rheumatoid arthritis by Chu C. Q. (1991)10.1093/rheumatology/31.10.653
10.1002/art.1780380710
10.1002/art.1780351008
10.1111/j.1365-2249.1992.tb06939.x
10.1097/00002281-199405000-00010
10.1002/art.1780360810
10.1084/jem.162.6.2163
10.1093/rheumatology/31.12.801
10.1002/art.1780351009
{'key': 'e_1_2_1_28_1', 'first-page': 'S39', 'article-title': 'Phase I study of recombinant human interleukin‐l receptor (RHUIL‐IR) administered intra‐articularly in active rheumatoid arthritis', 'volume': '36', 'author': 'Drevlow B.', 'year': '1993', 'journal-title': 'Arthritis Rheum.'}
/ Arthritis Rheum. / Phase I study of recombinant human interleukin‐l receptor (RHUIL‐IR) administered intra‐articularly in active rheumatoid arthritis by Drevlow B. (1993)10.1159/000236718
10.1002/art.1780361206
10.1016/S0140-6736(94)90628-9
10.1016/S0140-6736(94)90632-7
10.1136/ard.48.1.7
10.1016/0167-5699(93)90200-5
{'key': 'e_1_2_1_35_1', 'first-page': '109', 'volume-title': 'Clinical applications of cytokines: Role in pathogenesis, diagnosis and therapy', 'author': 'Feldmann M.', 'year': '1993'}
/ Clinical applications of cytokines: Role in pathogenesis, diagnosis and therapy by Feldmann M. (1993)10.1002/art.1780330602
10.1111/j.1365-3083.1993.tb01708.x
10.1016/0167-5699(93)90267-O
{'key': 'e_1_2_1_39_1', 'first-page': '515', 'article-title': 'Neutralization of interleukin‐β activity in vivo with a monoclonal antibody alleviates collagen‐induced arthritis in DBA/1 mice and prevents the associated acute‐phase response', 'volume': '11', 'author': 'Geiger T.', 'year': '1993', 'journal-title': 'Clin. Exp. Rheumatol.'}
/ Clin. Exp. Rheumatol. / Neutralization of interleukin‐β activity in vivo with a monoclonal antibody alleviates collagen‐induced arthritis in DBA/1 mice and prevents the associated acute‐phase response by Geiger T. (1993)10.1038/306378a0
10.1002/art.1780301102
10.1002/eji.1830211039
10.1016/S0140-6736(87)91158-5
{'key': 'e_1_2_1_44_1', 'first-page': '79', 'article-title': 'New therapeutic approaches in rheumatoid arthritis', 'volume': '7', 'author': 'Herzog C.', 'year': '1989', 'journal-title': 'Concepts Immunopathol.'}
/ Concepts Immunopathol. / New therapeutic approaches in rheumatoid arthritis by Herzog C. (1989)10.1002/eji.1830181122
{'issue': '3', 'key': 'e_1_2_1_46_1', 'first-page': 'S51', 'article-title': 'Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms', 'volume': '7', 'author': 'Holmdahl R.', 'year': '1989', 'journal-title': 'Clin. Exp. Rheumatol.'}
/ Clin. Exp. Rheumatol. / Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms by Holmdahl R. (1989)10.4049/jimmunol.141.3.834
/ J. Immunol. / In vivo administration with IL‐1 accelerates the development of collagen‐induced arthritis in mice by Hom J. T (1988)10.1002/eji.1830180608
10.1016/0140-6736(92)92294-P
10.1002/art.1780360203
10.1182/blood.V74.1.130.130
/ Blood / Chronic exposure to tumour necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice by Johnson R. A. (1989)10.1084/jem.179.5.1517
10.1002/j.1460-2075.1991.tb04978.x
10.1016/0161-5890(93)90106-L
{'key': 'e_1_2_1_55_1', 'first-page': '313', 'article-title': 'Immunolocalization of endothelia) and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues', 'volume': '64', 'author': 'Koch A. E.', 'year': '1991', 'journal-title': 'Lab. Invest.'}
/ Lab. Invest. / Immunolocalization of endothelia) and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues by Koch A. E. (1991)10.1006/clin.1993.1146
{'issue': '39', 'key': 'e_1_2_1_57_1', 'article-title': 'A dose‐ and regimen‐ranging study of IL‐I receptor antagonist in patients with rheumatoid arthritis', 'volume': '36', 'author': 'Lebsack M. E.', 'year': '1993', 'journal-title': 'Arthritis Rheum.'}
/ Arthritis Rheum. / A dose‐ and regimen‐ranging study of IL‐I receptor antagonist in patients with rheumatoid arthritis by Lebsack M. E. (1993){'key': 'e_1_2_1_58_1', 'first-page': '543', 'article-title': 'E‐selectin and intercellular adhesion mol‐ecule‐1 are released by activated human endothelial cells in vitro', 'volume': '77', 'author': 'Leeuwenberg J. F', 'year': '1992', 'journal-title': 'Immunology'}
/ Immunology / E‐selectin and intercellular adhesion mol‐ecule‐1 are released by activated human endothelial cells in vitro by Leeuwenberg J. F (1992)10.1073/pnas.86.2.636
{'key': 'e_1_2_1_60_1', 'first-page': 'S169', 'article-title': 'An analysis of the relative contribution of genetic and environmental factors to rheumatoid arthritis susceptibility', 'volume': '37', 'author': 'Macgregor A. J.', 'year': '1994', 'journal-title': 'Arthritis Rheum.'}
/ Arthritis Rheum. / An analysis of the relative contribution of genetic and environmental factors to rheumatoid arthritis susceptibility by Macgregor A. J. (1994)10.1093/rheumatology/33.8.697
10.1002/art.1780360412
10.1002/art.1780311012
10.1084/jem.174.4.791
10.1002/art.1780330819
10.1002/art.1780360304
{'key': 'e_1_2_1_67_1', 'first-page': 'S295', 'article-title': 'Soluble tumor necrosis factor receptor (sTNFR): results of a phase I dose‐escalation study in patients with rheumatoid arthritis', 'volume': '37', 'author': 'Moreland L. W', 'year': '1994', 'journal-title': 'Arthritis Rheum'}
/ Arthritis Rheum / Soluble tumor necrosis factor receptor (sTNFR): results of a phase I dose‐escalation study in patients with rheumatoid arthritis by Moreland L. W (1994){'key': 'e_1_2_1_68_1', 'first-page': 'S39', 'article-title': 'Double‐blind placebo‐controlled phase II trial of diphtheria‐interleukin ‐2 fusion toxin (DAB486II‐2) in patients with refractory rheumatoid arthritis (RA)', 'volume': '36', 'author': 'Moreland L. W', 'year': '1993', 'journal-title': 'Arthritis Rheum.'}
/ Arthritis Rheum. / Double‐blind placebo‐controlled phase II trial of diphtheria‐interleukin ‐2 fusion toxin (DAB486II‐2) in patients with refractory rheumatoid arthritis (RA) by Moreland L. W (1993)10.1016/S0065-2776(08)60652-5
10.1073/pnas.87.22.8884
{'key': 'e_1_2_1_71_1', 'first-page': 'S295', 'article-title': 'Multicenter trial of an anti‐CD5 immunoconjugate in rheumatoid arthritis (RA)', 'volume': '37', 'author': 'Olsen N. J.', 'year': '1994', 'journal-title': 'Arthiritis Rheum.'}
/ Arthiritis Rheum. / Multicenter trial of an anti‐CD5 immunoconjugate in rheumatoid arthritis (RA) by Olsen N. J. (1994)10.1126/science.1857971
10.1006/bbrc.1993.1637
10.1002/art.1780350702
10.1002/art.1780330403
10.1016/0006-291X(92)91234-H
{'key': 'e_1_2_1_77_1', 'first-page': '510', 'article-title': 'Evolution of collagen arthritis in mice is arrested by treatment with anti‐tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor', 'volume': '77', 'author': 'Piguet P. F.', 'year': '1992', 'journal-title': 'Immunology'}
/ Immunology / Evolution of collagen arthritis in mice is arrested by treatment with anti‐tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor by Piguet P. F. (1992)10.1016/S0889-857X(21)00171-X
/ Rheum. Dis. Clin. N. A. / What is the natural history of rheumatoid arthritis by Pincus T (1993)10.1084/jem.180.5.1961
10.1084/jem.162.3.1105
{'key': 'e_1_2_1_81_1', 'first-page': 'S295', 'article-title': 'A double blind, placebo‐controlled, ascending dose trial of the recombinant humanised anti‐TNFα antibody CDP571 in patients with rheumatoid arthritis (RA): A preliminary report', 'volume': '37', 'author': 'Rankin E. C', 'year': '1994', 'journal-title': 'Arthritis Rheum.'}
/ Arthritis Rheum. / A double blind, placebo‐controlled, ascending dose trial of the recombinant humanised anti‐TNFα antibody CDP571 in patients with rheumatoid arthritis (RA): A preliminary report by Rankin E. C (1994)10.1002/art.1780370707
{'key': 'e_1_2_1_83_1', 'first-page': '171', 'article-title': 'Mechanisms of erythroid suppression in the anemia of chronic disease', 'volume': '18', 'author': 'Roodman G. D.', 'year': '1987', 'journal-title': 'Blood cells'}
/ Blood cells / Mechanisms of erythroid suppression in the anemia of chronic disease by Roodman G. D. (1987)10.1111/1523-1747.ep12580902
10.1084/jem.162.4.1208
10.1016/1043-4666(91)90013-4
10.1093/oso/9780192623560.001.0001
/ Epidemiology of the Rheumatic Diseases by Silman A. J. (1993)10.1093/rheumatology/32.10.903
10.1073/pnas.91.18.8562
10.1146/annurev.iy.02.040184.001215
10.1002/art.1780370211
10.1073/pnas.89.16.7375
10.1126/science.8378772
10.1111/j.1365-2249.1994.tb06517.x
{'key': 'e_1_2_1_95_1', 'first-page': 'S294', 'article-title': 'Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis; a placebo‐controlled trial', 'volume': '37', 'author': 'Lubbe P. A.', 'year': '1994', 'journal-title': 'Arthritis Rheum.'}
/ Arthritis Rheum. / Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis; a placebo‐controlled trial by Lubbe P. A. (1994)10.1146/annurev.iy.10.040192.002211
10.1126/science.2047874
10.1111/j.1365-2249.1993.tb03413.x
{'key': 'e_1_2_1_99_1', 'first-page': '259', 'article-title': 'Treatment of severe rheumatoid arthritis by anti‐interleukin 6 monoclonal antibody', 'volume': '20', 'author': 'Wendling D', 'year': '1993', 'journal-title': 'J. Rheumatol.'}
/ J. Rheumatol. / Treatment of severe rheumatoid arthritis by anti‐interleukin 6 monoclonal antibody by Wendling D (1993)10.1073/pnas.89.20.9784
{'key': 'e_1_2_1_101_1', 'first-page': '433', 'article-title': 'Successful therapy of collagen‐induced arthritis with TNF receptor‐IgG fusion protein and combination with anti‐CD4', 'volume': '84', 'author': 'Williams R. O.', 'year': '1995', 'journal-title': 'Immunology'}
/ Immunology / Successful therapy of collagen‐induced arthritis with TNF receptor‐IgG fusion protein and combination with anti‐CD4 by Williams R. O. (1995)10.1073/pnas.91.7.2762
10.4049/jimmunol.151.11.6602
/ J. Immunol. / Influence of a recombinant human soluble tumour necrosis factor receptor Fc fusion protein on type 11 collagen‐induced arthritis in mice by Wooley P. H. (1993)10.1002/art.1780360915
Dates
Type | When |
---|---|
Created | 19 years, 4 months ago (April 29, 2006, 7:20 p.m.) |
Deposited | 1 year, 7 months ago (Feb. 3, 2024, 11:16 p.m.) |
Indexed | 2 months, 2 weeks ago (June 20, 2025, 8:06 a.m.) |
Issued | 30 years, 5 months ago (April 1, 1995) |
Published | 30 years, 5 months ago (April 1, 1995) |
Published Online | 19 years, 4 months ago (April 28, 2006) |
Published Print | 30 years, 5 months ago (April 1, 1995) |
@article{MAINI_1995, title={Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease}, volume={144}, ISSN={1600-065X}, url={http://dx.doi.org/10.1111/j.1600-065x.1995.tb00070.x}, DOI={10.1111/j.1600-065x.1995.tb00070.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={MAINI, RAVINDER N. and ELLIOTT, MICHAEL J. and BRENNAN, EIONULA M. and WILLIAMS, RICHARD O. and CHU, CONG QIU and PALEOLOG, EWA and CHARLES, PETER J. and TAYLOR, PETER C. and FELDMANN, MARC}, year={1995}, month=apr, pages={195–223} }